“The advent of mobile phones and other devices has opened up new channels for pharmaceutical marketers to reach patients and caregivers. The Pharma industry as a whole is late to the digital game so logically patients and caregivers have pre-existing expectations of the digital experience. Digital enables brands to deliver highly targeted information in a variety of forms. It creates the setting for a brand experience versus a promotional moment.
This is a tremendous opportunity but not one without challenges – one of the biggest obstacles being lack of clear direction from the FDA around appropriate use of social media. Based upon this statement by Ernest Voyard, the FDA’s senior regulator council, guidance around appropriate use of social media will not be issued in the near future. “We are working on the area and it’s something we feel is important but we don’t have a specific timeline right now”.
While many companies have a digital presence via their brand websites and social network sites (SNS) they are not truly engaging the patient. At the same time, there are companies that are bold; willing to take risks and serve as industry pioneers.
The report, “The Digital Patient – A Snapshot of the Digital Landscape of Patients and Caregivers”, was written to provide support and guidance to companies with their digital strategy and planning. CBR Pharma Insights used both primary and secondary market research to produce analytical insights for pharma companies in support of their mobile, social, brand, and overall digital strategies.
Please Note: This product is delivered as a zip file
– Evolution of Direct to Consumer Marketing
– Creating a Digital Experience for Patients and Caregivers
– Patients and Care Givers Use of Digital Channels – findings from CBR Pharma Insight studies
– Digital Marketing Around the Industry
Key Reasons to Purchase
– Access a deep dive on how patients & caregivers are using digital technology to access...